Adamis Pharmaceuticals Announces 2020 Financial Results and Business Update
15 avr. 2021 16h39 HE
|
Adamis Pharmaceuticals Corporation
Phase 2/3 clinical trial for Tempol for the prevention of hospitalizations in patients with COVID-19 expected to initiate in the second quarter of 2021 Management to host webcast/conference call...
Adamis Pharmaceuticals Schedules Fourth Quarter and Full Year 2020 Financial Results Conference Call and Business Update
13 avr. 2021 16h03 HE
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, April 13, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty products for respiratory...
Adamis Pharmaceuticals Provides an Update on ZIMHI™
12 avr. 2021 07h00 HE
|
Adamis Pharmaceuticals Corporation
SAN DIEGO, April 12, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today provided an update on the status of the company’s New Drug Application (NDA) relating to its...
Deaths in Toronto Shelters at All Time High: CEO of Heart to Heart CPR Says That Shelter Staff is Taking the Wrong Course – A Claim Recently Supported by Newest Canadian 2020 Resuscitation Guidelines Released October 19, 2020
21 oct. 2020 09h16 HE
|
Heart to Heart First Aid CPR Services Inc
TORONTO, Oct. 21, 2020 (GLOBE NEWSWIRE) -- Nick Rondinelli, CEO of Heart to Heart CPR, issued the following announcement: My name is Nick Rondinelli, CEO of Heart to Heart First Aid CPR Services...
Global Opioid Drugs Markets 2019-2020 & Forecast to 2028: Increased Number of Lawsuits Against the Manufacturers of Opioid Drugs Restraining Growth
29 sept. 2020 06h24 HE
|
Research and Markets
Dublin, Sept. 29, 2020 (GLOBE NEWSWIRE) -- The "Global Opioid Drugs Market 2019-2028" report has been added to ResearchAndMarkets.com's offering. The global opioids drug market to proliferate with...
Prescription Drug Monitoring Programs Don’t Work, according to Article in the Journal of American Physicians and Surgeons
13 juin 2019 12h25 HE
|
Association of American Physicians and Surgeons
TUCSON, Ariz., June 13, 2019 (GLOBE NEWSWIRE) -- In response to the rising rate of drug overdose deaths, 49 states had a Prescription Drug Monitoring Program (PDMP) by 2014. By requiring physicians...
BioCorRx, Inc. Announces Preliminary Agreement with VDM Biochemicals to Develop and Commercialize Patented Opioid Antagonist VDM-001
09 oct. 2018 08h00 HE
|
BioCorRx Inc
ANAHEIM, CA, Oct. 09, 2018 (GLOBE NEWSWIRE) -- VDM-001 represents potential alternative to naloxone for overdose reversal; Potential to reduce cravings from substance use disorder via...
Heroin Detox Clinics Outlines The Opioid Epidemic And New Healthcare Guidelines
16 avr. 2018 22h25 HE
|
Heroin Detox Clinics
SAN DIEGO, April 16, 2018 (GLOBE NEWSWIRE) -- HeroinDetoxClinics.com is responsible for providing helpful information for individuals looking for answers about drug addiction. The website breaks...
Physicians Enter a Minefield When Prescribing Opioids, according to the Journal of American Physicians and Surgeons
14 déc. 2017 09h52 HE
|
Association of American Physicians and Surgeons
TUCSON, Ariz., Dec. 14, 2017 (GLOBE NEWSWIRE) -- As deaths from opioid overdoses soar, the government is targeting physicians for blame, writes Lawrence Huntoon, M.D., Ph.D., in the winter issue of...
AXIM Biotech CEO Appointed to American Pain Association Board of Advisors, Addresses American Opioid Abuse Epidemic
31 mars 2016 09h00 HE
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, March 31, 2016 (GLOBE NEWSWIRE) -- Dr. George E. Anastassov, MD, DDS, MBA and Chief Executive Officer of AXIM® Biotechnologies, Inc. (OTC:AXIM) was recently appointed to the American Pain...